Skip to main content
. 2016 Nov 24;6:253. doi: 10.3389/fonc.2016.00253

Figure 4.

Figure 4

Kaplan–Meier curves for PFS (left) or OS (right) calculated from date of first treatment start for metastatic disease according to the urine (A) or plasma (B) biomarker score level. The prospective cohort of patients (N = 23) was classified as “Low” (solid) vs. “High” (dashed) biomarker score at the time of sampling.